Glasgow, Scotland – 29 April 2026. EnteroBiotix Limited (‘EnteroBiotix’), a biopharmaceutical company developing best-in-class microbiome therapies for gut health, today announces the completion of a £19m ($25m) financing to advance its lead candidate, EBX-102-02, a next-generation orally delivered full-spectrum investigational microbiome therapeutic, into Phase 2b development for Irritable Bowel Syndrome with Constipation (IBS-C).
Austin, United States, May 25, 2026 (GLOBE NEWSWIRE) -- “According to SNS Insider, the Microneedle Drug Delivery Systems Market size was valued at USD 7.04 Billion in 2025 and is expected to reach USD 14.37 Billion by 2035, growing at a CAGR of 7.4% from 2026–2035.”
Hong Kong, Hong Kong, May 25, 2026 (GLOBE NEWSWIRE) -- Maple Tree Counselling, an international counselling and psychotherapy practice operating across Hong Kong, Central Victoria and Melbourne, continues to expand its evidence-based mental health services through a growing team of therapists trained in Cognitive Behaviour Therapy (CBT), Acceptance and Commitment Therapy (ACT), Somatic Therapy, EMDR…
Cannes, France , May 25, 2026 (GLOBE NEWSWIRE) -- CZR Exchange today announced that Founder and CEO Charlie Rothkopf has attended the 2026 Cannes Film Festival, reinforcing the company’s growing international presence and highlighting the expanding convergence between digital finance, technology, entertainment, and global culture.
NEW YORK, May 25, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Gossamer Bio, Inc. (NASDAQ: GOSS) and certain of its officers.
